Caris Life Sciences
(NASDAQ) CAI
Caris Life Sciences Financials at a Glance
Market Cap
$5.20B
Revenue (TTM)
$812.03M
Net Income (TTM)
$68.09M
EPS (TTM)
$-1.92
P/E Ratio
-9.61
Dividend
$0.00
Beta (Volatility)
0.38 (Low)
Dividend
$0.00
Beta (Volatility)
0.38 (Low)
Price
$18.41
Volume
122,329
Open
$18.71
Price
$18.41
Volume
122,329
Open
$18.71
Previous Close
$18.41
Daily Range
$17.96 - $19.12
52-Week Range
$17.15 - $42.50
Dividend
$0.00
Beta (Volatility)
0.38 (Low)
Price
$18.41
Volume
122,329
Open
$18.71
Previous Close
$18.41
Daily Range
$17.96 - $19.12
52-Week Range
$17.15 - $42.50
CAI News
CAI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Caris Life Sciences
Industry
Biotechnology
Sector
Health CareEmployees
1,846
CEO
David Dean Halbert
Website
www.carislifesciences.comHeadquarters
Irving, TX 75039, US
CAI Financials
Key Financial Metrics (TTM)
Gross Margin
66%
Operating Margin
6%
Net Income Margin
-8%
Return on Equity
-45%
Return on Capital
5%
Return on Assets
-6%
Earnings Yield
-10.41%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.20B
Shares Outstanding
282.58M
Volume
122.33K
Short Interest
0.00%
Avg. Volume
2.43M
Financials (TTM)
Gross Profit
$539.17M
Operating Income
$45.11M
EBITDA
$11.38M
Operating Cash Flow
$83.16M
Capital Expenditure
$16.26M
Free Cash Flow
$66.89M
Cash & ST Invst.
$800.09M
Total Debt
$378.99M
Caris Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$292.89M
+192.7%
Gross Profit
$220.91M
+488.3%
Gross Margin
75.43%
N/A
Market Cap
$5.20B
N/A
Market Cap/Employee
$2.94M
N/A
Employees
1,769
N/A
Net Income
$81.96M
+223.8%
EBITDA
$90.43M
+321.1%
Quarterly Fundamentals
Net Cash
$421.10M
+119.0%
Accounts Receivable
$112.14M
-41.2%
Inventory
$0.00
N/A
Long Term Debt
$378.82M
-81.9%
Short Term Debt
$169.00K
-99.9%
Return on Assets
-6.05%
N/A
Return on Invested Capital
4.52%
N/A
Free Cash Flow
$5.66M
+108.6%
Operating Cash Flow
$13.44M
+121.4%